Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 136.75M P/E - EPS this Y -12.50% Ern Qtrly Grth -
Income -30.09M Forward P/E -4.32 EPS next Y -11.10% 50D Avg Chg 4.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 33.00%
Dividend N/A Price/Book 1.21 EPS next 5Y - 52W High Chg -22.00%
Recommedations 2.00 Quick Ratio 16.90 Shares Outstanding 125.30M 52W Low Chg 116.00%
Insider Own 0.06% ROA -17.85% Shares Float 117.48M Beta 1.24
Inst Own 12.98% ROE -28.80% Shares Shorted/Prior 10.56M/7.15M Price 1.08
Gross Margin - Profit Margin - Avg. Volume 958,264 Target Price 4.58
Oper. Margin - Earnings Date May 13 Volume 450,656 Change -1.82%
About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines in the areas of unmet medical need in oncology. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201 for lung injury caused by cancer treatment. In addition, the company develops immunotherapy/chimeric antigen receptor therapy programs. It has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Atossa Therapeutics, Inc. News
04/15/24 Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
04/11/24 Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
04/09/24 Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
04/01/24 Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
03/19/24 Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient
03/18/24 Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
03/12/24 Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
03/06/24 Data from Atossa’s Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Cancer Research (AACR) Annual Meeting
03/03/24 We Think Atossa Therapeutics (NASDAQ:ATOS) Can Afford To Drive Business Growth
02/22/24 Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS Study
02/07/24 Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
01/22/24 Atossa Therapeutics, Inc. (NASDAQ:ATOS): Is Breakeven Near?
01/09/24 Atossa Therapeutics Issues Letter to Shareholders
12/08/23 Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
12/04/23 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
11/20/23 Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial
11/13/23 Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
11/09/23 Atossa Therapeutics Appoints Financial Executive Jonathan Finn to its Board of Directors
10/30/23 Quantum Leap Healthcare Collaborative Initiates Landmark Phase 2 RECAST DCIS Platform Trial to Evaluate Alternative DCIS Treatments with Atossa Therapeutics, Havah Therapeutics, and the Menarini Group
10/11/23 Fast-food consumption by adolescent girls may sow the seeds of breast cancer decades later
ATOS Chatroom

User Image Mrcroz Posted - 2 minutes ago

$ATOS brutal day

User Image CalmB4TheStormz Posted - 29 minutes ago

$ATOS Very common for small cap bio to build up into an anticipated PR/conference and then sell off. They are cyclical. Not just this one, all of them. Learn this and accept it. Make money on both up and down. Until ph3/BO/partner/stellar results, gains like this will not be sustained. Play the market, not your emotions. Make some money folks! This drop is not very shocking.

User Image shkspr Posted - 30 minutes ago

$ATOS Short or long positions are equal; they are simply legal tools used to generate profit. What occurred with GME was considered by Wall Street as a market inefficiency, and they excel at rectifying such scenarios. If you favor SQ, focus on stocks with low float, where short positions exceed the daily average volume by at least 3x. ATOS does not meet this criteria.

User Image Bunster Posted - 49 minutes ago

$ATOS do u think the director knows evangeline est completion date is well into 2026 and for all we know may get pushed back further into 2027 or even 2028?Does he know that CFO Greg(the M&A specialist) left the building last year?

User Image artofficialintelligence Posted - 53 minutes ago

$ATOS Bitter small cap message boards are fascinating...

User Image Bunster Posted - 57 minutes ago

$ATOS Is it true that jonboy the director is down 25pct on his insider buy in a week?????He probably paid too much attention to HS DM and the other cult and cheerleaders and did not take any of primes atos history classes.

User Image deepf00kinvalue Posted - 57 minutes ago

$ATOS 32,350 shares @ 1.16... Chilling till buyout. Going to keep accumulating more through the rest of this year.

User Image Jpred Posted - 1 hour ago

$ATOS bought last week [email protected] today bought 2000 @1.33 Now average down to 1.76 Let’s hope back above 2 soon

User Image Dirigodave207 Posted - 1 hour ago

$ATOS I’ll just set a buy .15 cents under the closing price every night before bed at this point. I bought at 1.37 earlier with a 1.36 stop and it lasted 10 minutes. 🤣. Perma bulls are getting slaughtered. Shorts are in complete control right now.

User Image Jpred Posted - 1 hour ago

$ATOS why Down so much ?

User Image ShowMeThaMonay Posted - 1 hour ago

$ATOS so what will tomorrow bring? 😅

User Image The_Real_Heisenberg Posted - 1 hour ago

$ATOS sad to say it is BECAUSE of GME that it won't ever happen again. They rigged the market even more after GME. Retail orders rarely hit the market directly. Citadel and Blackrock and many others got together and made it so only they can affect the price. They just fulfil your orders on paper and match it with a synthetic short that banks never force collect. Shorts just sit and sit and sit until retail let's go. Buying more doesn't help. What does help is other institutions who aren't on the same side... but challenging blackrock or citadel without just about every other hedge competing is a fools game. So they play along side them anyway. If retail had their power back, this stock would've hit well over $10 by now.

User Image Michaeljin_101 Posted - 1 hour ago

$ATOS i think all the turmoils done by the doctor, he could finally break away from the company, leaving all small investors penniless. A speculation on my sense.

User Image The_Real_Heisenberg Posted - 2 hours ago

$ATOS It's so depressing seeing other bios pop on much less. What's different about ATOS? It's too good?

User Image Mad_Macks Posted - 2 hours ago

$ATOS hold the line Quay! This shareholder wants a deal with big pharma but not at a steep steep discount before the data that’s coming. 💪🏻 It’s annoying to see the sp pushed down with the latest results. But that’s just how the market moves and idc what happens to the sp before the P2 data that’s coming 2H. If it gets pushed down I’ll just try to add when I can. 🤷🏼‍♂️

User Image Hastein Posted - 2 hours ago

$ATOS $1 Where's Hannibal? Did he hide?

User Image The_Real_Heisenberg Posted - 2 hours ago

$ATOS I just wanted 3.00... I didn't need 5, or 10, I just wanted 3..

User Image Bunster Posted - 2 hours ago

$ATOS what bothers prime some is at this pps the russell 2k reconstitute in a month or so is in jeopardy. PRIME.BIG Differemce in mkt cap betwenn 2.00 per share and 1.30.

User Image Mad_Macks Posted - 2 hours ago


User Image artofficialintelligence Posted - 3 hours ago

$ATOS Raise your hand if the "I told you so" posts are helpful...I'll wait.

User Image kinostreams Posted - 3 hours ago

$ATOS You just know this is what shkspr looks like:

User Image kinostreams Posted - 3 hours ago

$ATOS Suprised? No. Disgusted? Absolutely! That’s fine though. Ignore the shorts dancing on our graves at the moment. They are operating in the short term, while most bulls are operating on a longer timeframe. We’ve received some amazing news with Eli Lilly. The second half of this year will have 3 or 4 big data catalysts. We went to 2.30 on one patient being cancer free along with 7 patients in the 40mg cohort. A total of 8 people got us there! Now think about this: Karisma had 240 people in their trial. This is for a preventative cancer drug, which is basically an untapped market. The 80mg cohort group data will also come around the same time AND I-SPY2 data is expected in the second half of this year. These are the KNOWN catalysts. Unknown catalysts like the Eli Lilly announcement can pop up along the way. Still very very

User Image wiselyMoneyHunter Posted - 3 hours ago


User Image shkspr Posted - 3 hours ago


User Image Kittyc803 Posted - 4 hours ago

$ATOS Whatever pffffft !!! Lords of the dark pool . Looking down on us . 🖕🖕🖕

User Image Chairman5 Posted - 4 hours ago

$ATOS i told all those that can hear that conferences are always sell time. always buy a month before and sell a day or two before. name me one major finding released by some schmo giving an abstract and it will be the first!! listen to me and learn and make money. i’m telling you…don’t touch this before 1.10!

User Image Utzk_OptimusPrimeVersion Posted - 4 hours ago

$ATOS sentiment is horrible, which usually indicates opportunity. larger market momentarily bleak, if you invest 3-4 mos out, great buying time in my eyes.

User Image TheChangedBull Posted - 4 hours ago

$ATOS yikes what happened today? Down 80 cents in the last few days here.

User Image GSPfedorSilva Posted - 4 hours ago

$ATOS Probably not a catalyst, but the ASCO abstract titles are posted a week from now. At least we know big pharma is very much aware of atossa. Still can't get how mindblowing Monday's news was. LLY has a market cap of over 700 BILLION dollars. I wonder what else the doc has brewing.

User Image Dirigodave207 Posted - 4 hours ago

$ATOS this chart is UGLY. Set your buys for 1.05. There’s no support anywhere close.

Analyst Ratings
HC Wainwright & Co. Buy Apr 16, 24
HC Wainwright & Co. Buy Apr 2, 24
HC Wainwright & Co. Buy Feb 12, 24
Cantor Fitzgerald Overweight Sep 8, 23
Ascendiant Capital Buy Sep 17, 20
Maxim Group Buy Dec 18, 19
Maxim Group Buy Jan 26, 18
Sidoti & Co. Neutral Oct 7, 13
Sidoti & Co. Buy Apr 15, 13